10-Q: Quarterly report

SEC announcementMay 17 16:33 ET · Announcements

Bowen Acquisition Corp Announces Merger Details in Press Release

TipRanksJan 25 04:21 ET

Health products company “Qianzhi Biotechnology” plans to go public in the US under the cover of SPAC

Qianzhi Group Holding (Cayman) Limited, the holding company of Shenzhen Qianzhi Biotechnology Co., Ltd., Shenzhen Qianzhi Biotechnology Co., Ltd. from Shenzhen, Guangdong, signed a merger agreement with SPAC (US special purpose acquisition company) Bowen Acquisition Corp (BOWN) to be listed on the US NASDAQ through a backshell SPAC.

瑞恩資本RyanbenCapitalJan 19 23:51 ET

Bowen Acquisition Agrees to Merge With Shenzhen Qianzhi BioTechnology

Bowen Acquisition (BOWN) said late Thursday it signed an agreement to merge with Shenzhen Qianzhi BioTechnology, a biotech firm in China. Under the terms, Bowen's wholly owned unit, Bowen Merger Sub,

MT NewswiresJan 19 11:06 ET

Express News | Trading Halt: Halt Status Updated at 6:55:00 AM ET: Quotation Resumption: News and Resumption Times

Moomoo 24/7Jan 19 06:55 ET

Bowen Acquisition Enters Into Merger Agreement With Shenzhen Qianzhi Biotech Company

Pursuant to the Merger Agreement, BOWN's wholly owned subsidiary, Bowen Merger Sub, a Cayman Islands exempted company, will merge (the "Merger" or the "Business Combination") with and into Qianzhi Gro

BenzingaJan 19 01:43 ET